Donna Shryer
CAR T-Cell Therapy Can Now Target Solid Tumors: Mouse Study
June 21, 2016 (Medical News Today)
In Phase 2 trials, chimeric antigen receptors (CARs), genetically engineered protein constructs, rewire T-cells in a patient’s own immune...
Kite’s CAR T-Cell Therapy Success
March 1, 2017 (The Scientist)
In the 6-month follow-up for a Phase 2 trial focused on 101 advanced non-Hodgkin lymphoma patients who underwent chimeric...
14 scientific definitions for a deeper understanding of CAR-T therapy
Many researchers, oncologists, and pharmaceutical companies hail CAR-T therapy as a “cure for cancer.” But what exactly is this evolving technology? How is it...
